

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of histone H3-K9 methylation (GO:0051570) | 7.62763359 |
| 2 | DNA replication-dependent nucleosome assembly (GO:0006335) | 7.60630035 |
| 3 | DNA replication-dependent nucleosome organization (GO:0034723) | 7.60630035 |
| 4 | chromatin assembly (GO:0031497) | 7.26162461 |
| 5 | nuclear pore complex assembly (GO:0051292) | 7.01962225 |
| 6 | nuclear pore organization (GO:0006999) | 6.33360598 |
| 7 | mitotic chromosome condensation (GO:0007076) | 6.03219910 |
| 8 | nucleosome assembly (GO:0006334) | 5.65546516 |
| 9 | pore complex assembly (GO:0046931) | 5.29617294 |
| 10 | negative regulation of histone methylation (GO:0031061) | 5.23455082 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 5.12764378 |
| 12 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.01856826 |
| 13 | sequestering of actin monomers (GO:0042989) | 4.97674485 |
| 14 | nucleosome organization (GO:0034728) | 4.85505212 |
| 15 | chromatin assembly or disassembly (GO:0006333) | 4.85367607 |
| 16 | protein-DNA complex assembly (GO:0065004) | 4.60766933 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.57189180 |
| 18 | antibacterial humoral response (GO:0019731) | 4.57045249 |
| 19 | dosage compensation (GO:0007549) | 4.44643676 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.33808712 |
| 21 | regulation of RNA export from nucleus (GO:0046831) | 4.24858801 |
| 22 | antimicrobial humoral response (GO:0019730) | 4.21170572 |
| 23 | innate immune response in mucosa (GO:0002227) | 4.19494178 |
| 24 | sister chromatid segregation (GO:0000819) | 4.18858853 |
| 25 | protein-DNA complex subunit organization (GO:0071824) | 4.10360437 |
| 26 | DNA duplex unwinding (GO:0032508) | 4.06290459 |
| 27 | DNA geometric change (GO:0032392) | 4.03904350 |
| 28 | protein localization to kinetochore (GO:0034501) | 4.00629027 |
| 29 | negative regulation of DNA repair (GO:0045738) | 3.99281853 |
| 30 | histone lysine demethylation (GO:0070076) | 3.98119045 |
| 31 | respiratory electron transport chain (GO:0022904) | 3.87498165 |
| 32 | protein complex biogenesis (GO:0070271) | 3.85767063 |
| 33 | histone demethylation (GO:0016577) | 3.85555863 |
| 34 | mitotic sister chromatid cohesion (GO:0007064) | 3.85185856 |
| 35 | chromosome condensation (GO:0030261) | 3.83710583 |
| 36 | determination of adult lifespan (GO:0008340) | 3.79497753 |
| 37 | electron transport chain (GO:0022900) | 3.79442005 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.75608895 |
| 39 | ATP synthesis coupled proton transport (GO:0015986) | 3.75608895 |
| 40 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.68685600 |
| 41 | regulation of protein polyubiquitination (GO:1902914) | 3.68394366 |
| 42 | regulation of gene silencing (GO:0060968) | 3.64670084 |
| 43 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.55652441 |
| 44 | regulation of translational fidelity (GO:0006450) | 3.55380193 |
| 45 | regulation of centriole replication (GO:0046599) | 3.54884083 |
| 46 | galactose catabolic process (GO:0019388) | 3.53690999 |
| 47 | iron-sulfur cluster assembly (GO:0016226) | 3.52846784 |
| 48 | metallo-sulfur cluster assembly (GO:0031163) | 3.52846784 |
| 49 | DNA deamination (GO:0045006) | 3.49344095 |
| 50 | translesion synthesis (GO:0019985) | 3.48866322 |
| 51 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.43960534 |
| 52 | DNA topological change (GO:0006265) | 3.42817296 |
| 53 | peptidyl-lysine dimethylation (GO:0018027) | 3.41917986 |
| 54 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.41565720 |
| 55 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.41565720 |
| 56 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.41565720 |
| 57 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.40997676 |
| 58 | chaperone-mediated protein transport (GO:0072321) | 3.40356404 |
| 59 | protein demethylation (GO:0006482) | 3.39168284 |
| 60 | protein dealkylation (GO:0008214) | 3.39168284 |
| 61 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.36540727 |
| 62 | regulation of sister chromatid cohesion (GO:0007063) | 3.36446411 |
| 63 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.35496045 |
| 64 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.35270457 |
| 65 | regulation of gene silencing by miRNA (GO:0060964) | 3.35270457 |
| 66 | regulation of gene silencing by RNA (GO:0060966) | 3.35270457 |
| 67 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.34543128 |
| 68 | protein localization to chromosome, centromeric region (GO:0071459) | 3.32946779 |
| 69 | cellular response to zinc ion (GO:0071294) | 3.32040257 |
| 70 | mitotic nuclear envelope disassembly (GO:0007077) | 3.31816067 |
| 71 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.29845785 |
| 72 | NADH dehydrogenase complex assembly (GO:0010257) | 3.29845785 |
| 73 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.29845785 |
| 74 | nuclear envelope disassembly (GO:0051081) | 3.28078155 |
| 75 | membrane disassembly (GO:0030397) | 3.28078155 |
| 76 | negative regulation of histone modification (GO:0031057) | 3.27460062 |
| 77 | DNA packaging (GO:0006323) | 3.27033090 |
| 78 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.26498627 |
| 79 | DNA conformation change (GO:0071103) | 3.25740572 |
| 80 | positive regulation of histone methylation (GO:0031062) | 3.25564104 |
| 81 | histone mRNA catabolic process (GO:0071044) | 3.25519290 |
| 82 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.21234519 |
| 83 | regulation of helicase activity (GO:0051095) | 3.18520239 |
| 84 | negative regulation of chromatin modification (GO:1903309) | 3.14254542 |
| 85 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.13209457 |
| 86 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.12273034 |
| 87 | mucosal immune response (GO:0002385) | 3.11865814 |
| 88 | regulation of DNA endoreduplication (GO:0032875) | 3.10957861 |
| 89 | positive regulation of chromosome segregation (GO:0051984) | 3.10758345 |
| 90 | platelet dense granule organization (GO:0060155) | 3.08402266 |
| 91 | regulation of histone methylation (GO:0031060) | 3.06977092 |
| 92 | cytidine deamination (GO:0009972) | 3.06673409 |
| 93 | cytidine metabolic process (GO:0046087) | 3.06673409 |
| 94 | cytidine catabolic process (GO:0006216) | 3.06673409 |
| 95 | regulation of centrosome duplication (GO:0010824) | 3.04399672 |
| 96 | protein K6-linked ubiquitination (GO:0085020) | 3.03474568 |
| 97 | pre-miRNA processing (GO:0031054) | 3.02825234 |
| 98 | histone H3-K36 demethylation (GO:0070544) | 3.02357336 |
| 99 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.01392063 |
| 100 | embryonic process involved in female pregnancy (GO:0060136) | 2.98954487 |
| 101 | regulation of mitotic spindle organization (GO:0060236) | 2.98739129 |
| 102 | positive regulation of T cell apoptotic process (GO:0070234) | 2.97791888 |
| 103 | resolution of meiotic recombination intermediates (GO:0000712) | 2.95045661 |
| 104 | viral transcription (GO:0019083) | 2.93135772 |
| 105 | spindle assembly involved in mitosis (GO:0090307) | 2.92576420 |
| 106 | organ or tissue specific immune response (GO:0002251) | 2.92439097 |
| 107 | regulation of spindle organization (GO:0090224) | 2.92438248 |
| 108 | regulation of centrosome cycle (GO:0046605) | 2.92336196 |
| 109 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.90889514 |
| 110 | histone H3-K9 demethylation (GO:0033169) | 2.90864885 |
| 111 | chromatin remodeling at centromere (GO:0031055) | 2.89605303 |
| 112 | protein neddylation (GO:0045116) | 2.89370808 |
| 113 | IMP biosynthetic process (GO:0006188) | 2.88937687 |
| 114 | histone H2A monoubiquitination (GO:0035518) | 2.88603464 |
| 115 | cytochrome complex assembly (GO:0017004) | 2.88308930 |
| 116 | protein insertion into membrane (GO:0051205) | 2.87157069 |
| 117 | barbed-end actin filament capping (GO:0051016) | 2.86364208 |
| 118 | amino sugar catabolic process (GO:0046348) | 2.85491041 |
| 119 | hydrogen ion transmembrane transport (GO:1902600) | 2.85338055 |
| 120 | negative regulation of B cell proliferation (GO:0030889) | 2.84753288 |
| 121 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.84741152 |
| 122 | GDP-mannose metabolic process (GO:0019673) | 2.84551799 |
| 123 | postreplication repair (GO:0006301) | 2.81490931 |
| 124 | CENP-A containing nucleosome assembly (GO:0034080) | 2.79641399 |
| 125 | mitotic sister chromatid segregation (GO:0000070) | 2.77511888 |
| 126 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.77341398 |
| 127 | response to UV-C (GO:0010225) | 2.75342571 |
| 128 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.74144995 |
| 129 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.74144995 |
| 130 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.72930447 |
| 131 | viral protein processing (GO:0019082) | 2.72287306 |
| 132 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.72029987 |
| 133 | virion attachment to host cell (GO:0019062) | 2.71809346 |
| 134 | adhesion of symbiont to host cell (GO:0044650) | 2.71809346 |
| 135 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.71504938 |
| 136 | hepatocyte apoptotic process (GO:0097284) | 2.70372534 |
| 137 | proton transport (GO:0015992) | 2.69957043 |
| 138 | ribosomal small subunit biogenesis (GO:0042274) | 2.68962119 |
| 139 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 2.68745996 |
| 140 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.68377945 |
| 141 | translational termination (GO:0006415) | 2.66801272 |
| 142 | eosinophil chemotaxis (GO:0048245) | 2.66252310 |
| 143 | negative regulation of histone acetylation (GO:0035067) | 2.66193244 |
| 144 | hydrogen transport (GO:0006818) | 2.65085785 |
| 145 | DNA replication-independent nucleosome organization (GO:0034724) | 2.63736368 |
| 146 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.63736368 |
| 147 | regulation of mononuclear cell migration (GO:0071675) | 2.63009273 |
| 148 | positive regulation of mitochondrial fission (GO:0090141) | 2.62861864 |
| 149 | nuclear envelope organization (GO:0006998) | 2.59286620 |
| 150 | regulation of chronic inflammatory response (GO:0002676) | 2.57127009 |
| 151 | mannosylation (GO:0097502) | 2.56623882 |
| 152 | protein localization to endoplasmic reticulum (GO:0070972) | 2.56131757 |
| 153 | protein targeting to ER (GO:0045047) | 2.54482763 |
| 154 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.52812381 |
| 155 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.52812381 |
| 156 | respiratory chain complex IV assembly (GO:0008535) | 2.51881436 |
| 157 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.51027110 |
| 158 | cotranslational protein targeting to membrane (GO:0006613) | 2.50954000 |
| 159 | L-phenylalanine catabolic process (GO:0006559) | 2.50736709 |
| 160 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.50736709 |
| 161 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.50106192 |
| 162 | galactose metabolic process (GO:0006012) | 2.44889390 |
| 163 | translational elongation (GO:0006414) | 2.44021508 |
| 164 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.43950640 |
| 165 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.41021412 |
| 166 | mitochondrial calcium ion transport (GO:0006851) | 2.40806226 |
| 167 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.40484377 |
| 168 | ATP biosynthetic process (GO:0006754) | 2.40430576 |
| 169 | negative regulation of appetite (GO:0032099) | 2.37633735 |
| 170 | negative regulation of response to food (GO:0032096) | 2.37633735 |
| 171 | viral life cycle (GO:0019058) | 2.37310126 |
| 172 | phagosome maturation (GO:0090382) | 2.36956044 |
| 173 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.36817216 |
| 174 | cellular response to interferon-beta (GO:0035458) | 2.36433639 |
| 175 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.35083196 |
| 176 | L-phenylalanine metabolic process (GO:0006558) | 2.35083196 |
| 177 | eosinophil migration (GO:0072677) | 2.32854405 |
| 178 | ubiquinone biosynthetic process (GO:0006744) | 2.31911848 |
| 179 | regulation of sequestering of triglyceride (GO:0010889) | 2.29193001 |
| 180 | cellular response to nicotine (GO:0071316) | 2.28950853 |
| 181 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.28802681 |
| 182 | negative regulation of cell killing (GO:0031342) | 2.28802681 |
| 183 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 2.27595816 |
| 184 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.27323113 |
| 185 | response to interferon-beta (GO:0035456) | 2.27267618 |
| 186 | cellular response to cadmium ion (GO:0071276) | 2.25339071 |
| 187 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.23258586 |
| 188 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.23258586 |
| 189 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.22906142 |
| 190 | response to dietary excess (GO:0002021) | 2.20922092 |
| 191 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.20691714 |
| 192 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.20681299 |
| 193 | termination of RNA polymerase III transcription (GO:0006386) | 2.20681299 |
| 194 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.19514103 |
| 195 | protein maturation by protein folding (GO:0022417) | 2.17812481 |
| 196 | tolerance induction (GO:0002507) | 2.17415123 |
| 197 | protein-cofactor linkage (GO:0018065) | 2.16662774 |
| 198 | negative regulation of amino acid transport (GO:0051956) | 2.14839579 |
| 199 | lymphocyte chemotaxis (GO:0048247) | 2.14836817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.96471896 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 5.31952268 |
| 3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.25394835 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.89130647 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.53663407 |
| 6 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.91638029 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.89280428 |
| 8 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.76367527 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.71628092 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68797717 |
| 11 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.64561736 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.64508163 |
| 13 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.55192087 |
| 14 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.31463447 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31322956 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27195092 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.19322908 |
| 18 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.18791890 |
| 19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.14933911 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.14728056 |
| 21 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.08154547 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 16.9705708 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95384853 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93018124 |
| 25 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.91436366 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89656693 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.85351814 |
| 28 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.81998882 |
| 29 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.80920210 |
| 30 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.80488505 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77427858 |
| 32 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.75354400 |
| 33 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.75290353 |
| 34 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.73086101 |
| 35 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.71924815 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.70354206 |
| 37 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.70269961 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69760628 |
| 39 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.69654087 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.62026000 |
| 41 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.61692862 |
| 42 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.60283612 |
| 43 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.59413036 |
| 44 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58342737 |
| 45 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.57875101 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.57146029 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.56122265 |
| 48 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.54796918 |
| 49 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53879214 |
| 50 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.53654610 |
| 51 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.51900997 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51642839 |
| 53 | P68_20966046_ChIP-Seq_HELA_Human | 1.51420645 |
| 54 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50661163 |
| 55 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.49813308 |
| 56 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.48985367 |
| 57 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.48865105 |
| 58 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.47896351 |
| 59 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.45561515 |
| 60 | SA1_27219007_Chip-Seq_Bcells_Human | 1.43611310 |
| 61 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.43030543 |
| 62 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.42718922 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40802577 |
| 64 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.39777336 |
| 65 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.39618416 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.37422215 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.37213950 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36822053 |
| 69 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.36409969 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.36240924 |
| 71 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.35862122 |
| 72 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.34880374 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33118607 |
| 74 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.30425538 |
| 75 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.29401107 |
| 76 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27934859 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26778605 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24395093 |
| 79 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.23758164 |
| 80 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22954815 |
| 81 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22243003 |
| 82 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.21861191 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20692866 |
| 84 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17569891 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17388935 |
| 86 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.17206333 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16291093 |
| 88 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.15501919 |
| 89 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.14688189 |
| 90 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14313959 |
| 91 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13097306 |
| 92 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12840139 |
| 93 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12539388 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12224219 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 1.11054951 |
| 96 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.10342684 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.08837185 |
| 98 | ERA_21632823_ChIP-Seq_H3396_Human | 1.08191608 |
| 99 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08188626 |
| 100 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.07321651 |
| 101 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.06591840 |
| 102 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.05796964 |
| 103 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.05695613 |
| 104 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05566619 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05031923 |
| 106 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.04967862 |
| 107 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.04761487 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.04478164 |
| 109 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04054800 |
| 110 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03719716 |
| 111 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03618741 |
| 112 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02573450 |
| 113 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01500749 |
| 114 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.00842878 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00348634 |
| 116 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00008563 |
| 117 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99956733 |
| 118 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99440016 |
| 119 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99394311 |
| 120 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.99353973 |
| 121 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.99289510 |
| 122 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98360679 |
| 123 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97859374 |
| 124 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.97829644 |
| 125 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97295818 |
| 126 | MYC_22102868_ChIP-Seq_BL_Human | 0.96973431 |
| 127 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.96904940 |
| 128 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.96874763 |
| 129 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.96678479 |
| 130 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.96552257 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95991192 |
| 132 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95517415 |
| 133 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95409289 |
| 134 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.94265484 |
| 135 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.93885828 |
| 136 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93500274 |
| 137 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.93099570 |
| 138 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92976110 |
| 139 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.92827595 |
| 140 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.92337022 |
| 141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.92135135 |
| 142 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91685265 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91552253 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.90121309 |
| 145 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.89333261 |
| 146 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88881529 |
| 147 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88348346 |
| 148 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.87419013 |
| 149 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87373858 |
| 150 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.86540762 |
| 151 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.86395053 |
| 152 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83933016 |
| 153 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.82791748 |
| 154 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81256467 |
| 155 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81097670 |
| 156 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.77185370 |
| 157 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75432405 |
| 158 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.74149146 |
| 159 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73258598 |
| 160 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.72711103 |
| 161 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.69461459 |
| 162 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.69161747 |
| 163 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.69161747 |
| 164 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68529724 |
| 165 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.67625950 |
| 166 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.67330483 |
| 167 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.67077107 |
| 168 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.65698960 |
| 169 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65543278 |
| 170 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.63097324 |
| 171 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.61900619 |
| 172 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.61266060 |
| 173 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.61227951 |
| 174 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.60612164 |
| 175 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.60584090 |
| 176 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.60161040 |
| 177 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.59773283 |
| 178 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.59163197 |
| 179 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.58868385 |
| 180 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.58005186 |
| 181 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.57949888 |
| 182 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.57524730 |
| 183 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.57452111 |
| 184 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.56692606 |
| 185 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.56281920 |
| 186 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.55925194 |
| 187 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.55375455 |
| 188 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.55176401 |
| 189 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.54909780 |
| 190 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.54756718 |
| 191 | MAF_26560356_Chip-Seq_TH1_Human | 0.54349110 |
| 192 | TP53_16413492_ChIP-PET_HCT116_Human | 0.52485447 |
| 193 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52415668 |
| 194 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.51549643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.59857040 |
| 2 | MP0010307_abnormal_tumor_latency | 3.80907584 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 3.75060851 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.70753556 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.70276997 |
| 6 | MP0002009_preneoplasia | 3.06914176 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.98868356 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.96309093 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.92180816 |
| 10 | MP0005671_abnormal_response_to | 2.66364687 |
| 11 | MP0002653_abnormal_ependyma_morphology | 2.49819026 |
| 12 | MP0008438_abnormal_cutaneous_collagen | 2.44802161 |
| 13 | MP0006054_spinal_hemorrhage | 2.43483766 |
| 14 | MP0003077_abnormal_cell_cycle | 2.27703965 |
| 15 | MP0009785_altered_susceptibility_to | 2.26698729 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.19521971 |
| 17 | MP0002006_tumorigenesis | 2.17395594 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.13376685 |
| 19 | MP0003186_abnormal_redox_activity | 2.10820831 |
| 20 | MP0000537_abnormal_urethra_morphology | 2.09760098 |
| 21 | MP0003279_aneurysm | 2.04876426 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.04702082 |
| 23 | MP0003724_increased_susceptibility_to | 2.01682587 |
| 24 | MP0009840_abnormal_foam_cell | 2.00655478 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 2.00118007 |
| 26 | MP0000371_diluted_coat_color | 1.93999547 |
| 27 | MP0008057_abnormal_DNA_replication | 1.93191353 |
| 28 | MP0003436_decreased_susceptibility_to | 1.92079124 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.89433238 |
| 30 | MP0001542_abnormal_bone_strength | 1.88963607 |
| 31 | MP0000343_altered_response_to | 1.87305442 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 1.86650194 |
| 33 | MP0003121_genomic_imprinting | 1.78700550 |
| 34 | MP0006082_CNS_inflammation | 1.73805911 |
| 35 | MP0003011_delayed_dark_adaptation | 1.70629462 |
| 36 | MP0000685_abnormal_immune_system | 1.69680263 |
| 37 | MP0001730_embryonic_growth_arrest | 1.68910249 |
| 38 | MP0009379_abnormal_foot_pigmentation | 1.68628715 |
| 39 | MP0003879_abnormal_hair_cell | 1.66548854 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.65639107 |
| 41 | MP0005670_abnormal_white_adipose | 1.61983726 |
| 42 | MP0004510_myositis | 1.61532394 |
| 43 | MP0000350_abnormal_cell_proliferation | 1.60051427 |
| 44 | MP0003787_abnormal_imprinting | 1.59560798 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.58423498 |
| 46 | MP0004197_abnormal_fetal_growth/weight/ | 1.57581416 |
| 47 | MP0005171_absent_coat_pigmentation | 1.56470088 |
| 48 | MP0001905_abnormal_dopamine_level | 1.55006347 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 1.54231343 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.53899931 |
| 51 | MP0002277_abnormal_respiratory_mucosa | 1.52449719 |
| 52 | MP0005025_abnormal_response_to | 1.51978550 |
| 53 | MP0002139_abnormal_hepatobiliary_system | 1.51257330 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.50810107 |
| 55 | MP0004808_abnormal_hematopoietic_stem | 1.49774913 |
| 56 | MP0001764_abnormal_homeostasis | 1.49222401 |
| 57 | MP0001790_abnormal_immune_system | 1.48999658 |
| 58 | MP0005387_immune_system_phenotype | 1.48999658 |
| 59 | MP0003091_abnormal_cell_migration | 1.48732157 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.46672754 |
| 61 | MP0002723_abnormal_immune_serum | 1.46241789 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 1.44754421 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.42273139 |
| 64 | MP0000733_abnormal_muscle_development | 1.39965584 |
| 65 | MP0006276_abnormal_autonomic_nervous | 1.39350288 |
| 66 | MP0003123_paternal_imprinting | 1.39101729 |
| 67 | MP0004957_abnormal_blastocyst_morpholog | 1.38585116 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.37792479 |
| 69 | MP0005408_hypopigmentation | 1.37708715 |
| 70 | MP0002933_joint_inflammation | 1.36377797 |
| 71 | MP0009764_decreased_sensitivity_to | 1.35923944 |
| 72 | MP0002084_abnormal_developmental_patter | 1.35208064 |
| 73 | MP0009333_abnormal_splenocyte_physiolog | 1.35183705 |
| 74 | MP0004130_abnormal_muscle_cell | 1.35112307 |
| 75 | MP0002092_abnormal_eye_morphology | 1.34331006 |
| 76 | MP0003646_muscle_fatigue | 1.33899553 |
| 77 | MP0010678_abnormal_skin_adnexa | 1.33047805 |
| 78 | MP0001293_anophthalmia | 1.32470816 |
| 79 | MP0004142_abnormal_muscle_tone | 1.30570376 |
| 80 | MP0001958_emphysema | 1.26908336 |
| 81 | MP0002419_abnormal_innate_immunity | 1.23887643 |
| 82 | MP0002697_abnormal_eye_size | 1.23665590 |
| 83 | MP0001697_abnormal_embryo_size | 1.21325001 |
| 84 | MP0001672_abnormal_embryogenesis/_devel | 1.20056887 |
| 85 | MP0005380_embryogenesis_phenotype | 1.20056887 |
| 86 | MP0002075_abnormal_coat/hair_pigmentati | 1.19872037 |
| 87 | MP0002420_abnormal_adaptive_immunity | 1.19269993 |
| 88 | MP0001819_abnormal_immune_cell | 1.17419289 |
| 89 | MP0006072_abnormal_retinal_apoptosis | 1.17286010 |
| 90 | MP0001984_abnormal_olfaction | 1.16676884 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.16451544 |
| 92 | MP0003878_abnormal_ear_physiology | 1.16373413 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 1.16373413 |
| 94 | MP0008877_abnormal_DNA_methylation | 1.15789205 |
| 95 | MP0001533_abnormal_skeleton_physiology | 1.14653248 |
| 96 | MP0001529_abnormal_vocalization | 1.14479094 |
| 97 | MP0008469_abnormal_protein_level | 1.13608983 |
| 98 | MP0002396_abnormal_hematopoietic_system | 1.13416686 |
| 99 | MP0002095_abnormal_skin_pigmentation | 1.11810947 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11413410 |
| 101 | MP0002088_abnormal_embryonic_growth/wei | 1.11133064 |
| 102 | MP0005275_abnormal_skin_tensile | 1.10723939 |
| 103 | MP0003984_embryonic_growth_retardation | 1.09705339 |
| 104 | MP0002909_abnormal_adrenal_gland | 1.09666920 |
| 105 | MP0002085_abnormal_embryonic_tissue | 1.09334040 |
| 106 | MP0002080_prenatal_lethality | 1.08050281 |
| 107 | MP0005391_vision/eye_phenotype | 1.07691957 |
| 108 | MP0000490_abnormal_crypts_of | 1.06246989 |
| 109 | MP0001915_intracranial_hemorrhage | 1.05243254 |
| 110 | MP0000751_myopathy | 1.05235460 |
| 111 | MP0003075_altered_response_to | 1.03985049 |
| 112 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03176361 |
| 113 | MP0000372_irregular_coat_pigmentation | 1.03046797 |
| 114 | MP0005023_abnormal_wound_healing | 1.02918200 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 1.02790283 |
| 116 | MP0002638_abnormal_pupillary_reflex | 1.02760540 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 1.02642281 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 1.02485081 |
| 119 | MP0004043_abnormal_pH_regulation | 1.02378349 |
| 120 | MP0008058_abnormal_DNA_repair | 1.00777900 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 1.00188606 |
| 122 | MP0001324_abnormal_eye_pigmentation | 0.99249490 |
| 123 | MP0005253_abnormal_eye_physiology | 0.99227684 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.98765289 |
| 125 | MP0005365_abnormal_bile_salt | 0.97762666 |
| 126 | MP0002163_abnormal_gland_morphology | 0.97630550 |
| 127 | MP0004185_abnormal_adipocyte_glucose | 0.97275426 |
| 128 | MP0000750_abnormal_muscle_regeneration | 0.97051543 |
| 129 | MP0002405_respiratory_system_inflammati | 0.97016676 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.96590379 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.95817616 |
| 132 | MP0002019_abnormal_tumor_incidence | 0.95615618 |
| 133 | MP0002295_abnormal_pulmonary_circulatio | 0.94641232 |
| 134 | MP0000604_amyloidosis | 0.94242186 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.92014612 |
| 136 | MP0003045_fibrosis | 0.90731015 |
| 137 | MP0005645_abnormal_hypothalamus_physiol | 0.90656530 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.89862053 |
| 139 | MP0001970_abnormal_pain_threshold | 0.89720671 |
| 140 | MP0005464_abnormal_platelet_physiology | 0.89095029 |
| 141 | MP0005535_abnormal_body_temperature | 0.88513986 |
| 142 | MP0005084_abnormal_gallbladder_morpholo | 0.88019317 |
| 143 | MP0002822_catalepsy | 0.87859486 |
| 144 | MP0004272_abnormal_basement_membrane | 0.87082601 |
| 145 | MP0000703_abnormal_thymus_morphology | 0.86833496 |
| 146 | MP0002733_abnormal_thermal_nociception | 0.86784929 |
| 147 | MP0008932_abnormal_embryonic_tissue | 0.86627087 |
| 148 | MP0003137_abnormal_impulse_conducting | 0.85221023 |
| 149 | MP0002102_abnormal_ear_morphology | 0.84655441 |
| 150 | MP0001501_abnormal_sleep_pattern | 0.83902344 |
| 151 | MP0001968_abnormal_touch/_nociception | 0.83812992 |
| 152 | MP0001800_abnormal_humoral_immune | 0.83790660 |
| 153 | MP0001186_pigmentation_phenotype | 0.83739814 |
| 154 | MP0008789_abnormal_olfactory_epithelium | 0.82997472 |
| 155 | MP0010329_abnormal_lipoprotein_level | 0.82624166 |
| 156 | MP0005187_abnormal_penis_morphology | 0.81557477 |
| 157 | MP0001986_abnormal_taste_sensitivity | 0.81477480 |
| 158 | MP0003195_calcinosis | 0.81114816 |
| 159 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81053895 |
| 160 | MP0001853_heart_inflammation | 0.80391895 |
| 161 | MP0002272_abnormal_nervous_system | 0.80118041 |
| 162 | MP0005257_abnormal_intraocular_pressure | 0.80061649 |
| 163 | MP0003172_abnormal_lysosome_physiology | 0.79990931 |
| 164 | MP0009703_decreased_birth_body | 0.79376879 |
| 165 | MP0005332_abnormal_amino_acid | 0.79343344 |
| 166 | MP0002925_abnormal_cardiovascular_devel | 0.79309294 |
| 167 | MP0005410_abnormal_fertilization | 0.79049702 |
| 168 | MP0000427_abnormal_hair_cycle | 0.78256675 |
| 169 | MP0004145_abnormal_muscle_electrophysio | 0.78098791 |
| 170 | MP0009763_increased_sensitivity_to | 0.77913715 |
| 171 | MP0002398_abnormal_bone_marrow | 0.76033695 |
| 172 | MP0009765_abnormal_xenobiotic_induced | 0.75901245 |
| 173 | MP0003866_abnormal_defecation | 0.75735176 |
| 174 | MP0000716_abnormal_immune_system | 0.75459819 |
| 175 | MP0003303_peritoneal_inflammation | 0.75156788 |
| 176 | MP0008770_decreased_survivor_rate | 0.73344491 |
| 177 | MP0005621_abnormal_cell_physiology | 0.73260025 |
| 178 | MP0008260_abnormal_autophagy | 0.73220364 |
| 179 | MP0002736_abnormal_nociception_after | 0.73172862 |
| 180 | MP0004019_abnormal_vitamin_homeostasis | 0.72963094 |
| 181 | MP0000049_abnormal_middle_ear | 0.72284971 |
| 182 | MP0000689_abnormal_spleen_morphology | 0.71859572 |
| 183 | MP0002722_abnormal_immune_system | 0.71808981 |
| 184 | MP0001873_stomach_inflammation | 0.71012537 |
| 185 | MP0002254_reproductive_system_inflammat | 0.70984403 |
| 186 | MP0001661_extended_life_span | 0.69715762 |
| 187 | MP0001835_abnormal_antigen_presentation | 0.68121479 |
| 188 | MP0000313_abnormal_cell_death | 0.67367683 |
| 189 | MP0000015_abnormal_ear_pigmentation | 0.65936863 |
| 190 | MP0004947_skin_inflammation | 0.64780233 |
| 191 | MP0000428_abnormal_craniofacial_morphol | 0.64161602 |
| 192 | MP0003283_abnormal_digestive_organ | 0.64133451 |
| 193 | MP0002452_abnormal_antigen_presenting | 0.63700342 |
| 194 | MP0005384_cellular_phenotype | 0.62309617 |
| 195 | MP0010155_abnormal_intestine_physiology | 0.61974892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.80627573 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.68938100 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.48337165 |
| 4 | Hepatocellular necrosis (HP:0001404) | 4.01111655 |
| 5 | Subacute progressive viral hepatitis (HP:0006572) | 3.88477949 |
| 6 | Acute encephalopathy (HP:0006846) | 3.87335143 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.87175118 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.86069559 |
| 9 | Renal Fanconi syndrome (HP:0001994) | 3.78596874 |
| 10 | Hepatic necrosis (HP:0002605) | 3.70365442 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.69251672 |
| 12 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.69251672 |
| 13 | Increased intramyocellular lipid droplets (HP:0012240) | 3.68218766 |
| 14 | Increased muscle lipid content (HP:0009058) | 3.67190045 |
| 15 | Cerebral aneurysm (HP:0004944) | 3.60593595 |
| 16 | Increased CSF lactate (HP:0002490) | 3.57181407 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47728657 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47728657 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47728657 |
| 20 | Absent frontal sinuses (HP:0002688) | 3.37275529 |
| 21 | Short 4th metacarpal (HP:0010044) | 3.29569990 |
| 22 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.29569990 |
| 23 | Increased hepatocellular lipid droplets (HP:0006565) | 3.27014096 |
| 24 | Hematochezia (HP:0002573) | 3.09458443 |
| 25 | Hypopigmentation of the fundus (HP:0007894) | 3.08257729 |
| 26 | Cutaneous melanoma (HP:0012056) | 3.06129635 |
| 27 | Polyphagia (HP:0002591) | 3.05925234 |
| 28 | Lipid accumulation in hepatocytes (HP:0006561) | 3.05021574 |
| 29 | Cerebral edema (HP:0002181) | 2.98515232 |
| 30 | Cortical dysplasia (HP:0002539) | 2.89692086 |
| 31 | Spastic diplegia (HP:0001264) | 2.87597527 |
| 32 | 3-Methylglutaconic aciduria (HP:0003535) | 2.83009036 |
| 33 | Astrocytoma (HP:0009592) | 2.82704714 |
| 34 | Abnormality of the astrocytes (HP:0100707) | 2.82704714 |
| 35 | Exertional dyspnea (HP:0002875) | 2.82673185 |
| 36 | Prolonged neonatal jaundice (HP:0006579) | 2.81927922 |
| 37 | Sandal gap (HP:0001852) | 2.80837704 |
| 38 | Ulnar bowing (HP:0003031) | 2.76246635 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.75280310 |
| 40 | Biliary tract neoplasm (HP:0100574) | 2.73972401 |
| 41 | Colon cancer (HP:0003003) | 2.72546531 |
| 42 | Exercise intolerance (HP:0003546) | 2.68818364 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.66897707 |
| 44 | Ependymoma (HP:0002888) | 2.65979293 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.64405732 |
| 46 | Optic disc pallor (HP:0000543) | 2.64265873 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.61786776 |
| 48 | Volvulus (HP:0002580) | 2.60148281 |
| 49 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.59016299 |
| 50 | Mutism (HP:0002300) | 2.58352000 |
| 51 | Lactic acidosis (HP:0003128) | 2.53495909 |
| 52 | Abnormality of renal resorption (HP:0011038) | 2.51253529 |
| 53 | Absent/shortened dynein arms (HP:0200106) | 2.49878817 |
| 54 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.49878817 |
| 55 | Resting tremor (HP:0002322) | 2.42428585 |
| 56 | Mitral valve prolapse (HP:0001634) | 2.42095686 |
| 57 | Heterotopia (HP:0002282) | 2.40339149 |
| 58 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39458615 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.38888889 |
| 60 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.38798297 |
| 61 | Gastrointestinal carcinoma (HP:0002672) | 2.38798297 |
| 62 | Abnormality of the fingertips (HP:0001211) | 2.37189603 |
| 63 | Respiratory failure (HP:0002878) | 2.36494174 |
| 64 | Progressive neurologic deterioration (HP:0002344) | 2.34981363 |
| 65 | Abnormality of the 4th metacarpal (HP:0010012) | 2.32364656 |
| 66 | Aortic aneurysm (HP:0004942) | 2.32206183 |
| 67 | Oligomenorrhea (HP:0000876) | 2.29217149 |
| 68 | Micronodular cirrhosis (HP:0001413) | 2.29193014 |
| 69 | Viral hepatitis (HP:0006562) | 2.28649010 |
| 70 | Rhabdomyosarcoma (HP:0002859) | 2.27579537 |
| 71 | Aplastic anemia (HP:0001915) | 2.26063440 |
| 72 | Ankle contracture (HP:0006466) | 2.25136025 |
| 73 | Glioma (HP:0009733) | 2.22489195 |
| 74 | Neoplasm of the oral cavity (HP:0100649) | 2.20929900 |
| 75 | Thyroiditis (HP:0100646) | 2.19586377 |
| 76 | Termporal pattern (HP:0011008) | 2.18343825 |
| 77 | Insidious onset (HP:0003587) | 2.18343825 |
| 78 | Increased serum lactate (HP:0002151) | 2.18021145 |
| 79 | Generalized aminoaciduria (HP:0002909) | 2.16119557 |
| 80 | Medulloblastoma (HP:0002885) | 2.15663049 |
| 81 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.15485913 |
| 82 | Fibrous tissue neoplasm (HP:0012316) | 2.13544183 |
| 83 | Emotional lability (HP:0000712) | 2.07623526 |
| 84 | Stomatitis (HP:0010280) | 2.07232389 |
| 85 | Macroorchidism (HP:0000053) | 2.07016088 |
| 86 | Renovascular hypertension (HP:0100817) | 2.05225941 |
| 87 | Dysostosis multiplex (HP:0000943) | 2.04010999 |
| 88 | Radial bowing (HP:0002986) | 2.03886464 |
| 89 | IgA deficiency (HP:0002720) | 2.02729211 |
| 90 | Aqueductal stenosis (HP:0002410) | 2.02689198 |
| 91 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.02616207 |
| 92 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.02616207 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 2.02444121 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.02444121 |
| 95 | Axonal loss (HP:0003447) | 2.02049697 |
| 96 | Colitis (HP:0002583) | 2.01285894 |
| 97 | Increased CSF protein (HP:0002922) | 2.00919115 |
| 98 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.00504719 |
| 99 | Increased IgM level (HP:0003496) | 1.99813554 |
| 100 | Increased density of long bones (HP:0006392) | 1.99285297 |
| 101 | Bowel diverticulosis (HP:0005222) | 1.98935054 |
| 102 | Mesangial abnormality (HP:0001966) | 1.98193534 |
| 103 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97195857 |
| 104 | Large earlobe (HP:0009748) | 1.96417149 |
| 105 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.95203098 |
| 106 | Purpura (HP:0000979) | 1.94059521 |
| 107 | Bicuspid aortic valve (HP:0001647) | 1.92952399 |
| 108 | Fibroma (HP:0010614) | 1.92689437 |
| 109 | Impulsivity (HP:0100710) | 1.92670311 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 1.92431582 |
| 111 | Glycosuria (HP:0003076) | 1.92431582 |
| 112 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91962760 |
| 113 | Neoplasm of the small intestine (HP:0100833) | 1.91251053 |
| 114 | High pitched voice (HP:0001620) | 1.90992729 |
| 115 | Abnormal number of erythroid precursors (HP:0012131) | 1.90893682 |
| 116 | Conjunctival telangiectasia (HP:0000524) | 1.90824166 |
| 117 | Abnormality of chromosome stability (HP:0003220) | 1.89958453 |
| 118 | Cafe-au-lait spot (HP:0000957) | 1.88114182 |
| 119 | Hypoplasia of the thymus (HP:0000778) | 1.87578685 |
| 120 | Selective tooth agenesis (HP:0001592) | 1.87574004 |
| 121 | Papilloma (HP:0012740) | 1.87412346 |
| 122 | Verrucae (HP:0200043) | 1.87412346 |
| 123 | Freckling (HP:0001480) | 1.87168900 |
| 124 | T lymphocytopenia (HP:0005403) | 1.86880976 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86866711 |
| 126 | Dicarboxylic aciduria (HP:0003215) | 1.86866711 |
| 127 | Lethargy (HP:0001254) | 1.86365100 |
| 128 | Hyperphosphaturia (HP:0003109) | 1.84898892 |
| 129 | Abnormal eating behavior (HP:0100738) | 1.84653554 |
| 130 | Truncal obesity (HP:0001956) | 1.84225283 |
| 131 | Missing ribs (HP:0000921) | 1.84109893 |
| 132 | Basal cell carcinoma (HP:0002671) | 1.83395201 |
| 133 | Persistence of primary teeth (HP:0006335) | 1.83274975 |
| 134 | Prominent nose (HP:0000448) | 1.82972330 |
| 135 | Agnosia (HP:0010524) | 1.82906112 |
| 136 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.80850478 |
| 137 | Cerebral palsy (HP:0100021) | 1.80762503 |
| 138 | 11 pairs of ribs (HP:0000878) | 1.80451812 |
| 139 | Abnormal ciliary motility (HP:0012262) | 1.80326205 |
| 140 | X-linked dominant inheritance (HP:0001423) | 1.80281441 |
| 141 | Deviation of the thumb (HP:0009603) | 1.80002969 |
| 142 | Abnormality of the nasal mucosa (HP:0000433) | 1.79789557 |
| 143 | Abnormal hemoglobin (HP:0011902) | 1.78632734 |
| 144 | Neoplasm of striated muscle (HP:0009728) | 1.78385138 |
| 145 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.78242333 |
| 146 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.78242333 |
| 147 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.78242333 |
| 148 | Obstructive lung disease (HP:0006536) | 1.77997218 |
| 149 | Chronic obstructive pulmonary disease (HP:0006510) | 1.77997218 |
| 150 | Petechiae (HP:0000967) | 1.77446016 |
| 151 | Bowing of the arm (HP:0006488) | 1.76478149 |
| 152 | Bowed forearm bones (HP:0003956) | 1.76478149 |
| 153 | Long toe (HP:0010511) | 1.75992236 |
| 154 | Abnormality of oral frenula (HP:0000190) | 1.75502496 |
| 155 | Abnormality of the calcaneus (HP:0008364) | 1.74939731 |
| 156 | Opisthotonus (HP:0002179) | 1.74750229 |
| 157 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.74558643 |
| 158 | Vomiting (HP:0002013) | 1.74145110 |
| 159 | CNS demyelination (HP:0007305) | 1.73288667 |
| 160 | Dilatation of the ascending aorta (HP:0005111) | 1.72637684 |
| 161 | Delayed CNS myelination (HP:0002188) | 1.72280093 |
| 162 | Bladder carcinoma (HP:0002862) | 1.72078398 |
| 163 | Bladder neoplasm (HP:0009725) | 1.72078398 |
| 164 | Ovarian neoplasm (HP:0100615) | 1.72071076 |
| 165 | Enlarged penis (HP:0000040) | 1.71853973 |
| 166 | Increased mean platelet volume (HP:0011877) | 1.71815053 |
| 167 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.71563333 |
| 168 | Peritonitis (HP:0002586) | 1.71547369 |
| 169 | Uterine neoplasm (HP:0010784) | 1.71354682 |
| 170 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.70858753 |
| 171 | Abnormality of the peritoneum (HP:0002585) | 1.70541092 |
| 172 | Failure to thrive in infancy (HP:0001531) | 1.69699458 |
| 173 | Agitation (HP:0000713) | 1.69673717 |
| 174 | Hypertensive crisis (HP:0100735) | 1.69564021 |
| 175 | Aortic regurgitation (HP:0001659) | 1.69014482 |
| 176 | Breast carcinoma (HP:0003002) | 1.68804327 |
| 177 | Intestinal polyposis (HP:0200008) | 1.68305631 |
| 178 | Papillary thyroid carcinoma (HP:0002895) | 1.68215948 |
| 179 | Type II lissencephaly (HP:0007260) | 1.68123019 |
| 180 | Xanthomatosis (HP:0000991) | 1.67618999 |
| 181 | Abnormality of T cell number (HP:0011839) | 1.66743205 |
| 182 | Amaurosis fugax (HP:0100576) | 1.66088394 |
| 183 | Buphthalmos (HP:0000557) | 1.65905633 |
| 184 | Retinal atrophy (HP:0001105) | 1.65903523 |
| 185 | Wrist flexion contracture (HP:0001239) | 1.65646232 |
| 186 | Nasal polyposis (HP:0100582) | 1.63791055 |
| 187 | Agammaglobulinemia (HP:0004432) | 1.63155428 |
| 188 | Amyloidosis (HP:0011034) | 1.61963153 |
| 189 | Hypergammaglobulinemia (HP:0010702) | 1.61465741 |
| 190 | Methylmalonic aciduria (HP:0012120) | 1.61123610 |
| 191 | Chronic hepatic failure (HP:0100626) | 1.60720257 |
| 192 | Leukodystrophy (HP:0002415) | 1.59766252 |
| 193 | Myokymia (HP:0002411) | 1.59703938 |
| 194 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.59534758 |
| 195 | Hepatosplenomegaly (HP:0001433) | 1.58418225 |
| 196 | Microretrognathia (HP:0000308) | 1.57425882 |
| 197 | Vertebral compression fractures (HP:0002953) | 1.56558014 |
| 198 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.55038922 |
| 199 | IgG deficiency (HP:0004315) | 1.55001009 |
| 200 | Redundant skin (HP:0001582) | 1.54114261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 7.97470503 |
| 2 | ZAK | 5.26990952 |
| 3 | TESK1 | 4.11444100 |
| 4 | BCKDK | 3.68504834 |
| 5 | SCYL2 | 3.15735065 |
| 6 | TESK2 | 3.03207868 |
| 7 | LIMK1 | 2.99384710 |
| 8 | MAP3K11 | 2.86955080 |
| 9 | MAP3K10 | 2.65695827 |
| 10 | PKN2 | 2.62480270 |
| 11 | TTN | 2.55242002 |
| 12 | TXK | 2.49165865 |
| 13 | EEF2K | 2.42307408 |
| 14 | FRK | 2.42232633 |
| 15 | PIM2 | 2.38269161 |
| 16 | VRK1 | 2.32944770 |
| 17 | CDC7 | 2.32407728 |
| 18 | ARAF | 2.24229651 |
| 19 | STK4 | 2.22132588 |
| 20 | RPS6KA5 | 2.15329146 |
| 21 | MAP3K12 | 2.15262478 |
| 22 | VRK2 | 2.11880193 |
| 23 | STK16 | 2.10345074 |
| 24 | KDR | 2.08240816 |
| 25 | MYLK | 1.97967035 |
| 26 | NME2 | 1.84592866 |
| 27 | CAMKK2 | 1.75618342 |
| 28 | MAP4K2 | 1.74648733 |
| 29 | MAP4K1 | 1.73797181 |
| 30 | RPS6KB2 | 1.67919848 |
| 31 | ABL2 | 1.67805468 |
| 32 | CDK9 | 1.58035630 |
| 33 | EPHB2 | 1.57703046 |
| 34 | NEK2 | 1.57598722 |
| 35 | FGFR2 | 1.55430961 |
| 36 | CAMKK1 | 1.53501122 |
| 37 | GRK7 | 1.51067105 |
| 38 | DYRK2 | 1.50977194 |
| 39 | TBK1 | 1.44364192 |
| 40 | MAP2K7 | 1.44262540 |
| 41 | PIM1 | 1.42760245 |
| 42 | SRPK1 | 1.39092227 |
| 43 | AURKB | 1.33986982 |
| 44 | MAPKAPK3 | 1.33063089 |
| 45 | CAMK1D | 1.31039784 |
| 46 | CDK19 | 1.27648526 |
| 47 | ADRBK2 | 1.27513935 |
| 48 | LATS1 | 1.27287186 |
| 49 | MAP3K8 | 1.25577309 |
| 50 | CHEK2 | 1.24529709 |
| 51 | GRK5 | 1.21702096 |
| 52 | ERN1 | 1.21289209 |
| 53 | LRRK2 | 1.20954260 |
| 54 | TAOK3 | 1.18181849 |
| 55 | PKN1 | 1.17619119 |
| 56 | PTK6 | 1.17534299 |
| 57 | SIK2 | 1.17247628 |
| 58 | FLT3 | 1.16405310 |
| 59 | CSNK1G3 | 1.14557600 |
| 60 | IKBKB | 1.12671729 |
| 61 | GRK6 | 1.12372071 |
| 62 | TRIB3 | 1.10766869 |
| 63 | EPHA2 | 1.06916115 |
| 64 | TAOK1 | 1.05646017 |
| 65 | CDK12 | 1.04676830 |
| 66 | FGFR3 | 1.01272319 |
| 67 | PINK1 | 0.99394282 |
| 68 | DYRK3 | 0.99349048 |
| 69 | STK10 | 0.97898954 |
| 70 | ADRBK1 | 0.97891548 |
| 71 | TAOK2 | 0.96330014 |
| 72 | MELK | 0.96187133 |
| 73 | WNK3 | 0.94760998 |
| 74 | ATR | 0.94475478 |
| 75 | DAPK3 | 0.93210854 |
| 76 | ILK | 0.92937699 |
| 77 | MST1R | 0.91697954 |
| 78 | CSNK1G2 | 0.91425405 |
| 79 | DYRK1B | 0.90937686 |
| 80 | PDGFRA | 0.86034123 |
| 81 | BLK | 0.84594008 |
| 82 | MARK1 | 0.84523804 |
| 83 | ZAP70 | 0.83556643 |
| 84 | ACVR1B | 0.81999753 |
| 85 | PASK | 0.81434482 |
| 86 | SYK | 0.81291122 |
| 87 | MAPK13 | 0.80546831 |
| 88 | CDK6 | 0.79463014 |
| 89 | PRKD3 | 0.76919404 |
| 90 | CSK | 0.75481563 |
| 91 | MAP3K13 | 0.74192567 |
| 92 | RIPK1 | 0.73710766 |
| 93 | PRKD2 | 0.72454905 |
| 94 | MET | 0.71813775 |
| 95 | IKBKE | 0.71433226 |
| 96 | DAPK1 | 0.70759100 |
| 97 | KSR1 | 0.70715502 |
| 98 | ATM | 0.69823738 |
| 99 | CSNK1A1L | 0.69037706 |
| 100 | GRK1 | 0.68847576 |
| 101 | TTK | 0.66798162 |
| 102 | PHKG1 | 0.65458052 |
| 103 | PHKG2 | 0.65458052 |
| 104 | WEE1 | 0.62438336 |
| 105 | MOS | 0.62174301 |
| 106 | STK3 | 0.61873430 |
| 107 | CHEK1 | 0.61800114 |
| 108 | TGFBR1 | 0.61161587 |
| 109 | RET | 0.61049829 |
| 110 | CDK4 | 0.60928546 |
| 111 | CSF1R | 0.60561454 |
| 112 | CSNK1G1 | 0.59262034 |
| 113 | FES | 0.58981455 |
| 114 | NEK1 | 0.58836335 |
| 115 | PAK1 | 0.57197633 |
| 116 | NUAK1 | 0.55048306 |
| 117 | TGFBR2 | 0.54559382 |
| 118 | PDGFRB | 0.54491434 |
| 119 | PLK1 | 0.54288768 |
| 120 | PRKAA1 | 0.54284431 |
| 121 | MTOR | 0.54140109 |
| 122 | CSNK1D | 0.54020830 |
| 123 | MAP3K2 | 0.53908130 |
| 124 | JAK1 | 0.53138097 |
| 125 | FGR | 0.52825311 |
| 126 | LYN | 0.51926383 |
| 127 | LCK | 0.51711270 |
| 128 | TYK2 | 0.51549678 |
| 129 | SIK1 | 0.50878355 |
| 130 | PAK6 | 0.50613062 |
| 131 | MAP2K4 | 0.50594182 |
| 132 | SGK3 | 0.49103266 |
| 133 | MAP3K14 | 0.49034154 |
| 134 | JAK2 | 0.48770867 |
| 135 | MAPK4 | 0.48336214 |
| 136 | CAMK2G | 0.48100965 |
| 137 | AKT2 | 0.47967071 |
| 138 | FGFR4 | 0.47641011 |
| 139 | MAPK12 | 0.47542192 |
| 140 | PAK2 | 0.47135476 |
| 141 | BTK | 0.46978428 |
| 142 | CDK14 | 0.46399564 |
| 143 | PRKCG | 0.45207636 |
| 144 | MATK | 0.44542766 |
| 145 | PRKACA | 0.44037072 |
| 146 | IRAK4 | 0.43731851 |
| 147 | MAP3K4 | 0.43220001 |
| 148 | MARK3 | 0.42715935 |
| 149 | PLK3 | 0.42383572 |
| 150 | CDK11A | 0.42025504 |
| 151 | CDK2 | 0.41740736 |
| 152 | BRAF | 0.40351145 |
| 153 | FGFR1 | 0.39976195 |
| 154 | PRKDC | 0.39883319 |
| 155 | PRKCD | 0.39768319 |
| 156 | CAMK1 | 0.39412647 |
| 157 | ROCK1 | 0.39289105 |
| 158 | PAK3 | 0.38934609 |
| 159 | WNK4 | 0.38745430 |
| 160 | MAPK15 | 0.38124786 |
| 161 | CHUK | 0.38100058 |
| 162 | CDC42BPA | 0.37648051 |
| 163 | PRKCQ | 0.36987224 |
| 164 | TRPM7 | 0.36589551 |
| 165 | PAK4 | 0.36104902 |
| 166 | CDK1 | 0.36050216 |
| 167 | GSK3A | 0.35704280 |
| 168 | FER | 0.35599445 |
| 169 | CAMK1G | 0.35419550 |
| 170 | SGK2 | 0.35128504 |
| 171 | INSR | 0.34639671 |
| 172 | TNK2 | 0.34331753 |
| 173 | MAP3K6 | 0.34286420 |
| 174 | IRAK3 | 0.33651737 |
| 175 | MAP3K5 | 0.33482381 |
| 176 | PIK3CA | 0.33355768 |
| 177 | SGK1 | 0.32122219 |
| 178 | AURKA | 0.31317220 |
| 179 | RPS6KB1 | 0.30494438 |
| 180 | RAF1 | 0.29949545 |
| 181 | EIF2AK3 | 0.29750166 |
| 182 | DDR2 | 0.29695940 |
| 183 | BUB1 | 0.29358202 |
| 184 | ITK | 0.29289373 |
| 185 | EGFR | 0.27492002 |
| 186 | BMX | 0.27163867 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Alcoholism_Homo sapiens_hsa05034 | 6.20029894 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.52550479 |
| 3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.45304956 |
| 4 | Viral carcinogenesis_Homo sapiens_hsa05203 | 3.41989548 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.99393429 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.83919126 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.63150900 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.43086858 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.41213920 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.24673559 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.08341226 |
| 12 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 11.0217225 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.97827747 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97196280 |
| 15 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.92087412 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91243484 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.87830974 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.86410575 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84458673 |
| 20 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.80217693 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70872803 |
| 22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51687073 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.51421462 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.48849498 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48513257 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44347301 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42524652 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.42464339 |
| 29 | Protein export_Homo sapiens_hsa03060 | 1.40477462 |
| 30 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.37317420 |
| 31 | DNA replication_Homo sapiens_hsa03030 | 1.36288387 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35157844 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.33025264 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.32371259 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.31880565 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30294792 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29555099 |
| 38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.25719191 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.23992676 |
| 40 | Cell cycle_Homo sapiens_hsa04110 | 1.23806987 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22092956 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.21986412 |
| 43 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.18686503 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.18035474 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13916808 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.13528157 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.12217502 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09456744 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.07685255 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05811029 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04851224 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 1.03744801 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.01670156 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01626272 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 1.00634684 |
| 56 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99466099 |
| 57 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.98897280 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96252439 |
| 59 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94909206 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94587387 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94060586 |
| 62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93260986 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.92952709 |
| 64 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.92382338 |
| 65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.92332208 |
| 66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.92140517 |
| 67 | RNA transport_Homo sapiens_hsa03013 | 0.88864126 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88724471 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.88028905 |
| 70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.86181672 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85771703 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85451018 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82952584 |
| 74 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.81617674 |
| 75 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.78953716 |
| 76 | Lysine degradation_Homo sapiens_hsa00310 | 0.77603329 |
| 77 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77249798 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77124193 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.75836634 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.75194491 |
| 81 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75016053 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74611323 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73854690 |
| 84 | Adherens junction_Homo sapiens_hsa04520 | 0.72867371 |
| 85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72711480 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70904978 |
| 87 | Phototransduction_Homo sapiens_hsa04744 | 0.70786252 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69857579 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69849922 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69743581 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69416141 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69404109 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69239596 |
| 94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.69027223 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.68935880 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.68141412 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65876600 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65870282 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65680706 |
| 100 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.64965482 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64405428 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.63757316 |
| 103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63755632 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.63751434 |
| 105 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63633797 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63523265 |
| 107 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63297597 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62711584 |
| 109 | Metabolic pathways_Homo sapiens_hsa01100 | 0.62541702 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.61777901 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61101813 |
| 112 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.61068395 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60488380 |
| 114 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.60200221 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59452935 |
| 116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58792344 |
| 117 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57662035 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56766062 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.56585924 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56407339 |
| 121 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.55613491 |
| 122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55342723 |
| 123 | Base excision repair_Homo sapiens_hsa03410 | 0.54969240 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53672410 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53379491 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.53106362 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52946319 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52684130 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51667546 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51457960 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51131108 |
| 132 | Hepatitis B_Homo sapiens_hsa05161 | 0.51040911 |
| 133 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49977096 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49786320 |
| 135 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48834397 |
| 136 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47495410 |
| 137 | Tight junction_Homo sapiens_hsa04530 | 0.47063493 |
| 138 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46981398 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.45679894 |
| 140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45521376 |
| 141 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.45173507 |
| 142 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44678368 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43257864 |
| 144 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42844778 |
| 145 | Morphine addiction_Homo sapiens_hsa05032 | 0.42758062 |
| 146 | Nicotine addiction_Homo sapiens_hsa05033 | 0.42582388 |
| 147 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42441170 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42036740 |
| 149 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41501753 |
| 150 | Measles_Homo sapiens_hsa05162 | 0.41046278 |
| 151 | Retinol metabolism_Homo sapiens_hsa00830 | 0.40826875 |
| 152 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39930472 |
| 153 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.39908041 |
| 154 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38769055 |
| 155 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38541350 |
| 156 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.38176460 |
| 157 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37667755 |
| 158 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36319636 |
| 159 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36213232 |
| 160 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36043589 |
| 161 | GABAergic synapse_Homo sapiens_hsa04727 | 0.36020019 |
| 162 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35819229 |
| 163 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34982833 |
| 164 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34571671 |
| 165 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34405826 |
| 166 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34376752 |
| 167 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.34124476 |
| 168 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34060209 |
| 169 | Amoebiasis_Homo sapiens_hsa05146 | 0.33954298 |
| 170 | Bladder cancer_Homo sapiens_hsa05219 | 0.33612560 |
| 171 | Spliceosome_Homo sapiens_hsa03040 | 0.32028979 |
| 172 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.31481111 |
| 173 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29980707 |
| 174 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29780173 |
| 175 | Homologous recombination_Homo sapiens_hsa03440 | 0.29450195 |
| 176 | Melanoma_Homo sapiens_hsa05218 | 0.29011979 |
| 177 | Influenza A_Homo sapiens_hsa05164 | 0.28137205 |
| 178 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27166940 |
| 179 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.26747241 |
| 180 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.26740325 |
| 181 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.26372145 |
| 182 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26088172 |
| 183 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.25734168 |
| 184 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24771604 |
| 185 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24568671 |
| 186 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.23055954 |
| 187 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22298444 |
| 188 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22274314 |
| 189 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20784124 |
| 190 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.20538543 |
| 191 | Thyroid cancer_Homo sapiens_hsa05216 | 0.20372854 |
| 192 | Legionellosis_Homo sapiens_hsa05134 | 0.20198487 |
| 193 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20128801 |

